Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1.

about

Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature.

P2860

Q55669129-10DBE6BB-9A27-4D6F-9FB2-25E2A9FF7683

P2860

Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1.

Item

http://www.wikidata.org/entity/Q47142832

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1.

@en

Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1.

@nl

type

Item

label

Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1.

@en

Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1.

@nl

prefLabel

Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1.

@en

Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1.

@nl

P1476

Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1.

@en

P2093

Byung Sik Kim

http://www.w3.org/2001/XMLSchema#string

Chang Mo Hwang

http://www.w3.org/2001/XMLSchema#string

Duane T Smoot

http://www.w3.org/2001/XMLSchema#string

Gi Seok Jeong

http://www.w3.org/2001/XMLSchema#string

Hassan Ashktorab

http://www.w3.org/2001/XMLSchema#string

Hee Sung Kim

http://www.w3.org/2001/XMLSchema#string

Myoung-Hee Kang

http://www.w3.org/2001/XMLSchema#string

Yun-Yong Park

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP

Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy

History and progression of Fat cadherins in health and disease

Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer

Verteporfin

The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis.

BRB-ArrayTools Data Archive for human cancer gene expression: a unique and efficient data sharing resource

Rapid prototyping of concave microwells for the formation of 3D multicellular cancer aggregates for drug screening.

In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection

Association between cadherin-17 expression and pathological characteristics of gastric cancer: a meta-analysis

P304

98887-98897

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.21946

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29228735

http://www.w3.org/2001/XMLSchema#string

P932

5716775

http://www.w3.org/2001/XMLSchema#string

Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1.

about

P2860

P2860

Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932